These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8680016)

  • 1. [Secretion of interleukin-1 beta and tumor necrosis factor by mononuclear cells in breast cancer patients: effect of body mass (composition), age and smoking].
    Bershteĭn LM; Poroshina TE
    Biull Eksp Biol Med; 1996 Jan; 121(1):91-3. PubMed ID: 8680016
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytokine release from mononuclear cells in patients irradiated for breast cancer.
    Wasserman J; Petrini B; Wolk G; Vedin I; Glas U; Blomgren H; Ekre HP; Strannegård O
    Anticancer Res; 1991; 11(1):461-4. PubMed ID: 1902078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
    Jablońska E; Kiluk M; Piotrowski L; Grabowska Z; Markiewicz W; Jablonski J
    Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered tumor necrosis factor alpha release from mononuclear cells of obese reproductive-age women during hyperglycemia.
    González F; Minium J; Rote NS; Kirwan JP
    Metabolism; 2006 Feb; 55(2):271-6. PubMed ID: 16423637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines, tryptophan and anorexia in cancer patients before and after surgical tumor ablation.
    Cangiano C; Testa U; Muscaritoli M; Meguid MM; Mulieri M; Laviano A; Cascino A; Preziosa I; Conversano L; Rossi Fanelli F
    Anticancer Res; 1994; 14(3B):1451-5. PubMed ID: 8067720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis.
    Rashid G; Korzets Z; Bernheim J
    Isr Med Assoc J; 2006 Jan; 8(1):36-9. PubMed ID: 16450750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relation between tumor necrosis factor secretion activity and serum FDP level in cancer patients: preliminary report].
    Ono H; Kikuchi S; Nakamura Y; Yamauchi A; Takahashi M; Machida T; Yoshida K
    Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1818. PubMed ID: 2594012
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of gammalinolenic acid on interleukin-1 beta and tumor necrosis factor-alpha secretion by stimulated human peripheral blood monocytes: studies in vitro and in vivo.
    DeLuca P; Rossetti RG; Alavian C; Karim P; Zurier RB
    J Investig Med; 1999 May; 47(5):246-50. PubMed ID: 10361385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous apoptosis of blood dendritic cells in patients with breast cancer.
    Pinzon-Charry A; Maxwell T; McGuckin MA; Schmidt C; Furnival C; López JA
    Breast Cancer Res; 2006; 8(1):R5. PubMed ID: 16417648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer.
    Madhusudan S; Foster M; Muthuramalingam SR; Braybrooke JP; Wilner S; Kaur K; Han C; Hoare S; Balkwill F; Talbot DC; Ganesan TS; Harris AL
    Clin Cancer Res; 2004 Oct; 10(19):6528-34. PubMed ID: 15475440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood insulin and insulin sensitivity in breast cancer patients of various ages: the effect of smoking].
    Tsyrlina EV; Gamaiunova VB; Kovalenko IG; Berstein LM
    Vopr Onkol; 1998; 44(1):43-8. PubMed ID: 9578730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.
    Zhang GJ; Adachi I
    Anticancer Res; 1999; 19(2B):1427-32. PubMed ID: 10365118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of tumor necrosis factor alpha and interleukin-1 receptor antagonist, but not interleukin-1, by human mononuclear cells is enhanced by exposure of whole blood to shear stress.
    Pomianek MJ; Colton CK; Dinarello CA; Miller LC
    ASAIO J; 1996; 42(1):52-9. PubMed ID: 8808459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does human relaxin-2 affect peripheral blood mononuclear cells to increase inflammatory mediators in pathologic bone loss?
    Kristiansson P; Holding C; Hughes S; Haynes D
    Ann N Y Acad Sci; 2005 May; 1041():317-9. PubMed ID: 15956727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
    Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromium chloride inhibits TNFalpha and IL-6 secretion in isolated human blood mononuclear cells exposed to high glucose.
    Jain SK; Lim G
    Horm Metab Res; 2006 Jan; 38(1):60-2. PubMed ID: 16477544
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro immunomodulatory effects of cuphiin D1 on human mononuclear cells.
    Wang CC; Chen LG; Yang LL
    Anticancer Res; 2002; 22(6C):4233-6. PubMed ID: 12553063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha enhances secretion of transforming growth factor beta2 in MCF-7 breast cancer cells.
    Danforth DN; Sgagias MK
    Clin Cancer Res; 1996 May; 2(5):827-35. PubMed ID: 9816237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secretion of tumor necrosis factor-alpha and interleukin 1 by placental macrophages in vitro during various pregnancy outcomes].
    Pavlov OV; Sel'kov SA; Seliutin AV; Anan'eva VV
    Biull Eksp Biol Med; 1999 Jul; 128(7):97-100. PubMed ID: 10485064
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy.
    Bozcuk H; Uslu G; Samur M; Yildiz M; Ozben T; Ozdoğan M; Artaç M; Altunbaş H; Akan I; Savaş B
    Cytokine; 2004 Jul 21-Aug 7; 27(2-3):58-65. PubMed ID: 15242694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.